States are keeping a close eye on Massachusetts as it attempts to wrangle prescription drug spending in its MassHealth program, The Meadville Tribune reports.
According to the report, Massachusetts Gov. Charlie Baker proposed giving power to health officials to post a drug’s value if it’s found to cost too much. Drug companies would also be required to testify on pricing information, and could face lawsuits if they refuse.
The proposed changes to MassHealth could put $80 million back in the state’s coffer, per the report.
“We think publicly posting the price of a drug is critical because it provides incentives for the drug manufacturers to come to the table to engage in negotiations,” Health Care for All Policy and Government Relations Co-Director Alyssa Vangeli tells the Tribue.
To read the full report, click here.
